EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterisation of APS‐1 Experimental Models Is Crucial for Development of Novel Therapies

Sarah Almaghrabi, Thomas Lovewell, Mimoun Azzouz, Rachid Tazi Ahnini iD

BioMed Research International · 2023

DOI: 10.1155/2023/7960443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, 2023. Verfasst von Sarah Almaghrabi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection, Immunity and Cardiovascular Disease, Sheffield, UK. Hauptthemen laut MEDLINE: Gene Expression Regulation, Thymocytes. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, SA Studentship from Saudi Ministry of High Education, MRC/LifeArc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune polyglandular syndrome type 1 (APS‐1) is an inherited autosomal disorder. The most common clinical features of the disease include adrenocortical failure, hypoparathyroidism (HP), and chronic mucocutaneous candidiasis (CMC). APS‐1 is caused by mutations in the autoimmune regulator (AIRE) gene. AIRE is a transcriptional factor involved in the regulation of thousands of genes in the thymus. It facilitates central tolerance by promoting the ectopic expression of tissue‐specific antigens (TSAs) in medullary thymic epithelial cells (mTECs), leading to the deletion of self‐reactive thymocytes. Several Aire‐deficient mice were developed separately, on different backgrounds; seven published Aire knockout mice show a variety of phenotypes depending on the strain used to generate the experimental model. The first Aire‐deficient mice were generated on a “black 6” background almost 20 years ago. The model showed mild phenotype with relatively modest penetrance compared to models generated on BALBc or NOD backgrounds. The generation of all these experimental models is crucial for development and testing new therapeutics as well as reading the response to treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Expression RegulationThymocytesMiceAnimalsMice, Inbred NODThymus GlandMutationAntigensMice, KnockoutEpithelial Cells

Substanzen

Antigens

Autor:innen und Institutionen

  • Department of Infection, Immunity and Cardiovascular Disease, Sheffield, UK.
  • Sheffield Institute for Translational Neuroscience (SITRaN), Department of Neuroscience, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.

ORCID-Profile: Rachid Tazi Ahnini

Förderung

  • Medical Research Council
  • SA Studentship from Saudi Ministry of High Education
  • MRC/LifeArc
  • L’Association Francaise contre les Myopathies
  • National Organisation for Rare Disorders

Zitieren

APA

Almaghrabi, S., Lovewell, T., Azzouz, M., & Tazi Ahnini, R. (2023). Characterisation of APS‐1 Experimental Models Is Crucial for Development of Novel Therapies. BioMed Research International. https://doi.org/10.1155/2023/7960443

Vancouver

Almaghrabi S, Lovewell T, Azzouz M, Tazi Ahnini R. Characterisation of APS‐1 Experimental Models Is Crucial for Development of Novel Therapies. BioMed Research International. 2023. doi:10.1155/2023/7960443

BibTeX
@article{Almaghrabi2023,
  author = {Almaghrabi, Sarah and Lovewell, Thomas and Azzouz, Mimoun and Tazi Ahnini, Rachid},
  title = {Characterisation of APS‐1 Experimental Models Is Crucial for Development of Novel Therapies},
  journal = {BioMed Research International},
  year = {2023},
  doi = {10.1155/2023/7960443}
}
Kostenlos starten →